课题基金 / 基金详情

Identification of human T-cell epitopes on Mycobacterium tuberculosis small molecular weight proteins and development of DNA vaccines based on the epitopes

Identification of human T-cell epitopes on Mycobacterium tuberculosis small molecular weight proteins and development of DNA vaccines based on the epitopes
结核分枝杆菌小分子量蛋白上人T细胞表位的鉴定以及基于该表位的DNA疫苗的开发
批准号:
16390130
负责人:
NAGATA Toshi
金额:
$8.96万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

NAGATA Toshi的其他基金

相似基金

相关文献

中文摘要
翻译
CD8~+细胞毒性T淋巴细胞(CTL)在抗结核分枝杆菌感染中起着关键作用。我们在HLAA^0201转基因HHD小鼠中发现了一个新的结核分枝杆菌保护性抗原MPT51的CTL表位。用基因枪法将编码MPT51基因的DNA免疫HHD小鼠,检测免疫小鼠脾细胞产生干扰素-γ的情况。对于合成的覆盖成熟MPT51序列的重叠多肽文库,只有一种多肽p51-70刺激脾细胞产生干扰素-γ。细胞表面CD4和CD8染色的三色流式细胞术分析表明,p51-70肽含有一个免疫优势的CD8~+T细胞表位。使用计算机辅助算法的进一步分析允许识别出真正的T细胞表位P53-62。用T2细胞进行MHC-I类稳定实验证实,该表位由人类白细胞抗原A^*0201呈递。观察到MPT51、P53-62/HLA0201四聚体能与免疫HHD脾细胞的CD8+T细胞结合。此外,在结核菌素皮肤试验阳性的正常人中还发现了MPT51、P53-62特异的记忆性CD8^+T细胞。该HLAA^0201限制性CD8+T细胞表位可用于分析MPT51特异性T细胞在保护性免疫中的作用,并用于未来抗结核分枝杆菌感染的疫苗设计。
英文摘要
CD8^+ cytotoxic T lymphocytes (CTL) play a pivotal role in protection against Mycobacterium tuberculosis infection. We identified a novel CTL epitope on a protective antigen of M. tuberculosis, MPT51, in HLA-A^*0201-transgenic HHD mice. HHD mice were immunized with plasmid DNA encoding MPT51 using gene gun and interferon (IFN)-y production from the immune splenocytes was analyzed. In response to synthetic overlapping peptide library covering the mature MPT51 sequence, only one peptide, p51-70, stimulated the splenocytes to produce IFN-y. Three-color flow cytometric analysis of cell-surface CD4 and CD8 staining revealed that p51-70 peptide contains an immunodominant CD8^+ T-cell epitope. Further analysis using computer-assisted algorithms permitted identification of a bona fide T-cell epitope, p53-62. MHC class I stabilization assay using T2 cells confirmed that the epitope is presented by HLA-A^*0201. MPT51 p53-62/HLA-A^*0201 tetramer was observed to bind to the specific CD8^+ T cells of immune HHD splenocytes. In addition, MPT51 p53-62-specific memory CD8^+ T cells were found in tuberculin skin test-positive HLA-A^*0201^+ healthy individuals. This HLA-A^*0201-restricted CD8^+ T-cell epitope would be feasible for analysis of the role of MPT51-specific T cells in protective immunity and for future vaccine design against M. tuberculosis infection.
期刊论文(44)
专著(0)
科研奖励(0)
会议论文
Expression mapping by retroviral vector for CD8+ T cell epitopes : definition of a Mycobacterium tuberculosis peptide presented by H2-D^d.
CD8 T 细胞表位逆转录病毒载体的表达作图:H2-D^d 呈现的结核分枝杆菌肽的定义。
DOI: --
发表时间: 2005
期刊: J. Immunol. Methods 298
影响因子: --
作者: [Aoshi, T., Suzuki, M., Uchijima, M., Nagata, T., Koide, Y.]
通讯作者: Y.
Identification of MHC-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
结核分枝杆菌新型保护性抗原 MPT51 上 MHC 限制性 T 细胞表位的鉴定。
DOI: --
发表时间: 2004
期刊: Int. J. Infect. Dis. 8
影响因子: --
作者: [Koide, Y., Suzuki, M., Aoshi, T., Nagata, T.]
通讯作者: T.
Identification of H2-D^d- and H2-A^b-restricted T-cell epitopes on a novel protective antigen, MPT51, of Mycobacterium tuberculosis.
结核分枝杆菌新型保护性抗原 MPT51 上 H2-D^d- 和 H2-A^b- 限制性 T 细胞表位的鉴定。
DOI: --
发表时间: 2004
期刊: Infect. Immun. 72・7
影响因子: --
作者: [Suzuki, M., Aoshi, T., Nagata, T., Koide, Y.]
通讯作者: Y.
Interferon-γ overcomes low responsiveness of myeloid dendritic cells to CpG-DNA.
干扰素-γ 克服了骨髓树突状细胞对 CpG-DNA 的低反应性。
DOI: --
发表时间: 2005
期刊: Immunol Cell Biol 83
影响因子: --
作者: [Uchijima M, Nagata T, Aoshi T, Koide Y]
通讯作者: Koide Y
共 19 条
    Evaluation of the mechanisms underlying carbon cycles mediated by microbial food web networks in meso- and bathypelagic layers of the oceans
    • 批准号:
      24241003
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $28.95万
    • 财政年份:
      2012
    • 负责人:
      NAGATA Toshi
    • 依托单位:
    Dynamic Control of Molecular Functions via Time-Dependent External Stimuli
    • 批准号:
      22550133
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2010
    • 负责人:
      NAGATA Toshi
    • 依托单位:
    Evaluation of mechanisms underlying the formation of viral hot spot observed in the mid latitude region of the North Pacific
    • 批准号:
      22651004
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.27万
    • 财政年份:
      2010
    • 负责人:
      NAGATA Toshi
    • 依托单位:
    Resource Recycling of Carbon Dioxide with Catalysis by Heteromultinuclear Metal Complexes
    • 批准号:
      21200057
    • 项目类别:
      Grant-in-Aid for Scientific Research on Innovative Areas (Research a proposed research project)
    • 资助金额:
      $19.39万
    • 财政年份:
      2009
    • 负责人:
      NAGATA Toshi
    • 依托单位:
    国内基金
    海外基金
    鲜驴乳中游离脂肪酸对Mycobacterium tuberculosis H37Rv活性的影响及机制研究
    • 批准号:
      31760442
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      38.0万元
    • 批准年份:
      2017
    • 负责人:
      许倩
    • 依托单位:
    靶向结核杆菌细胞壁ManLAM的多肽型显像剂,用于鉴别诊断结核病灶与肿瘤病灶的实验研究
    • 批准号:
      30970859
    • 项目类别:
      面上项目
    • 资助金额:
      32.0万元
    • 批准年份:
      2009
    • 负责人:
      唐恭顺
    • 依托单位:
    PKB/AKT1介导的结核杆菌感染及防治的分子机制研究
    • 批准号:
      30871117
    • 项目类别:
      面上项目
    • 资助金额:
      31.0万元
    • 批准年份:
      2008
    • 负责人:
      范红
    • 依托单位:
    应用ELISPOT和四聚体技术研究结核与艾滋病相关结核诊断试剂
    • 批准号:
      30430660
    • 项目类别:
      重点项目
    • 资助金额:
      105.0万元
    • 批准年份:
      2004
    • 负责人:
      赖小敏
    • 依托单位: